MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

10 Apr 2017 Evaluate

Glenmark Pharmaceuticals has informed about press release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..